United Therapeutics (UTHR) Inventory Average (2010 - 2026)

United Therapeutics (UTHR) has 17 years of Inventory Average data on file, last reported at $180.7 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory Average rose 11.78% year-over-year to $180.7 million; the trailing twelve-month figure through Mar 2026 stood at $180.7 million (up 11.78% YoY), and the FY2025 full-year result was $170.5 million, up 26.44% from the prior year.
• Inventory Average grew to $180.7 million in Q1 2026, from $179.8 million in the prior quarter.
• In the past five years, Inventory Average ranged from a high of $180.7 million in Q1 2026 to a low of $89.0 million in Q2 2022.
• A 5-year average of $128.5 million and a median of $116.0 million in 2024 frame the typical range for Inventory Average.
• Across the five-year window, Inventory Average declined 3.05% in 2022 and jumped 40.95% in 2024, its largest moves.
• Tracing UTHR's Inventory Average over 5 years: stood at $96.5 million in 2022, then climbed by 11.97% to $108.0 million in 2023, then jumped by 40.95% to $152.3 million in 2024, then grew by 18.06% to $179.8 million in 2025, then grew by 0.5% to $180.7 million in 2026.
• Business Quant data shows UTHR's Inventory Average at $180.7 million in Q1 2026, $179.8 million in Q4 2025, and $172.8 million in Q3 2025.